LNC Therapeutics (FR)

https://www.lnctherapeutics.com

LinkedIn: https://fr.linkedin.com/company/lnc-therapeutics

Founded in 2010, LNC Therapeutics is a French biotech company specialized in research & development for gut microbiome-based drugs. All of the company’s projects include basic research, preclinical research and clinical trials. Backed by leading venture capital investors such as Seventure Partners (with the microbiome-dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of €16.5 million raised so far including €1.5 million in grants from BPIfrance and the Aquitaine Region, LNC Therapeutics is pursuing its ambitious research and development programs to create the therapies of the future. *

	Start	2010-01-01 established
	Industry	microbiomic treatment (live biotherapeutic product, LBP)
	Industry 2	microbiomics
	Person	Rawadi, Georges (LNC Therapeutics 201804– CEO before Celyad/Cardio3 BioSciences + Cellectis + Galapagos + ProStrakan)
	Person 2	Treillou, Jean-Luc (LNC Therapeutics 201807– Chairman before CEO)

	Region	Bordeaux
	Country	France
	Street	17 Place de la Bourse
	City	33076 Bordeaux cedex
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: LNC Therapeutics. (4/17/18). "Press Release: LNC Therapeutics Appoints New CEO, Dr. Georges Rawadi, and Accelerates Development in Microbiome Research". Bordeaux.

		Record changed: 2024-02-12

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for LNC Therapeutics (FR)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)